精选70MarketWatch（RSS）股市多源精选 ×2
礼来营收飙升48%，GLP-1药物需求强劲
Lilly’s revenue soars 48%, driven by demand for its GLP-1s
Lilly’s sales were driven by higher-than-expected demand for Mounjaro and Zepbound, its GLP-1 drugs for Type 2 diabetes and weight loss.
更进一步：量化金融体系
看懂新闻只是起点——沿量化金融路径，把它变成能交付的工程能力